The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Covidien

  • COV
  • NYSE
  • Consumer Products
  • Latest 91.37
  • Currency US$
  • Change 0.37
  • Percent Change 0.407 %
  • Volume 5,239,404
  • Fri Jul 11, 2014 04:00 PM EDT NYSE data delayed 15 minutes.
  • Open 91.00
  • Previous Close 91.00
  • High 91.49
  • Low 90.73
  • Bidx0 89.00
  • Askx0 92.03
  • 52-week High06/16 92.68
  • 52-week Low07/11 57.535
  • Beta 1.197
  • Market Cap 41,185.03M
  • EPS 3.78
  • P/E 24.172
  • Forward P/E 20.63
  • PEG 2.25
  • Annual Dividend 1.28
  • Yield 1.401

News

Financials & Calendars

Income Statement

  • Sales $10,375,000,000
  • Earnings $1,607,000,000
  • Return on Equity 16.95%

Cash Flow

  • Cash Flow --
  • Cash $1,178,000,000
  • Current Ratio 2.04

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $20,507,000,000
  • Liabilities $10,945,000,000
  • Liabilities-to-Equity Ratio 1.14

Price Ratios

  • Price to Sales 3.97
  • Price to Book 4.31
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Apr 25 $0.95 Jul 25 $1.00
Surprises Apr 25 1.05% n/a n/a
Dividends Apr 3 $0.32 n/a n/a
Splits n/a -- n/a n/a

12 months ended Jul 13, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Covidien PLC, formerly Covidien Ltd, is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its business through four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. The Medical Devices segment includes the development, manufacture and sale of endomechanical, soft tissue repair, energy, oximetry and monitoring, airway and ventilation, vascular, SharpSafety and clinical care products; Imaging Solutions, which includes the development, manufacture and marketing of radiopharmaceuticals and contrast products; Pharmaceutical Products, which includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, which includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products.

Related Securities
Symbol Type Latest % Chg

Officers

  • Jose E. Almeida Chairman;President and C.E.O
  • Charles J. Dockendorff C.F.O. and Exec. V.P.
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

20 ON HATCH LOWER HATCH STREET
DUBLIN, L2
DUBLIN

Phone: (353)-1438-1700

cole.lannum@covidien.com
www.covidien.com

Ideas & Discussion

Live Discussion of COV on StockTwits